Economic Impact Among Family Caregivers of Patients With Advanced Ovarian Cancer

Angioli, Roberto; Capriglione, Stella; Aloisi, Alessia; Miranda, Andrea; Nardone, Carlo De Cicco; Terranova, Corrado; Adrower, Roberto; Plotti, Francesco

doi:10.1097/igc.0000000000000512

Cited by 31 publications

(30 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Caregivers experienced three main types of cost: the cost of informal care time ( n = 13), OOPCs ( n = 6) and costs related to the impact on the caregivers' work ( n = 12). Four studies (Angioli et al, ; Chai, Guerriere, Zagorski, & Coyte, ; Chai, Guerriere, Zagorski, Kennedy, & Coyte, ; Li et al, ) only reported an overall value for the combined costs of care time and time lost from work‚ with one study (Angioli et al, ) also including some OOPCs. The remaining studies reported discrete values for the cost of informal care time (47%, n = 9), OOPCs (26%, n = 5) and costs related to the impact on the caregivers' work (42%, n = 8).…”

Section: Resultsmentioning

confidence: 99%

“…Four studies only reported aggregated costs of informal care, including a combination of costs related to care time, time lost from work and/or OOPCs. These estimates ranged from $750 to $12,334 per month (Angioli et al, ; Chai et al, , ; Li et al, ). These studies included different costs in their measurements, which partially explains the wide range of estimates.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The direct and indirect financial costs of informal cancer care: A scoping review

Coumoundouros

Brahim

Lambert

et al. 2019

Health Soc Care Community

View full text Add to dashboard Cite

Informal caregivers are the primary source of support for cancer patients, providing assistance with household tasks, medical care and emotional support. These responsibilities often result in high levels of emotional, physical, social and financial burden for the caregiver. The aim of this study was to perform a scoping review exploring what is known regarding the financial costs experienced by caregivers and identify gaps in the literature. Seven databases were searched for articles published between May 2008 and May 2018 related to direct and indirect costs of informal cancer care. Included articles reported on the costs incurred by cancer caregivers as a dollar value, relied on caregiver‐reported costs and were peer reviewed. A total of 19 studies met the inclusion criteria. These studies reported out of pocket costs‚ opportunity costs of informal care time and caregiver time loss from paid employment. Care time was the largest source of cancer caregiver costs, averaging $4,809 per month when valued using the proxy good method or $2,877 per month when the opportunity cost approach was used. Caregiver costs were highest when the care recipient was in the palliative phase of the disease. There was an absence of literature reporting costs for cancer caregivers in low and middle income countries and none of the included studies considered costs related to the caregivers' medical expenditures. There were many challenges when comparing the costs across studies due to variations in the type of expenses reported and the methods used to value expenses. Quantifying the financial costs associated with being an informal caregiver can facilitate the communication of the financial burden caregivers experience, potentially spurring the development of policies and programs to reduce their financial burden and better support cancer caregivers.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

The direct and indirect financial costs of informal cancer care: A scoping review

Coumoundouros

Brahim

Lambert

et al. 2019

Health Soc Care Community

View full text Add to dashboard Cite

show abstract

“…Gynecologic cancers place a considerable economic burden on society [8]. The national direct medical costs for cancer were estimated at $80.2 billion in the United States in 2015 [9].…”

Section: Introductionmentioning

confidence: 99%

Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014

et al. 2020

View full text Add to dashboard Cite

Objective: This study estimated nationally representative medical expenditures of gynecologic cancers, described treatment patterns and assessed key risk factors associated with the economic burden in the United States. Methods: A retrospective repeated measures design was used to estimate the effect of gynecologic cancers on medical expenditures and utilization among women. Data were extracted from the Medical Expenditure Panel Survey (weighted sample of 609,787 US adults) from 2007 to 2014. Using the behavioral model of health services utilization, characteristics of cancer patients were examined and compared among uterine, cervical, and ovarian cancer patients. Multivariable linear regression models were conducted on medical expenditure with a prior logarithmic transformation.

show abstract

“…A recent economic analysis of caregiving in advanced ovarian cancer patients demonstrated that, in addition to the patient, there are significant burdens that cancer treatment puts on the patients' families and the society at large (Angioli et al 2015). Given the complexity and often prolonged nature of the disease, the life of patient with ovarian cancer and potentially the family members face multiple challenges, including financial toxicity.…”

Section: Economic Impactmentioning

confidence: 99%

Drug Resistance in Bacteria, Fungi, Malaria, and Cancer

Godman

Fadare

Kibuule

et al. 2017

View full text Add to dashboard Cite

Economic Impact Among Family Caregivers of Patients With Advanced Ovarian Cancer

Cited by 31 publications

References 29 publications

The direct and indirect financial costs of informal cancer care: A scoping review

The direct and indirect financial costs of informal cancer care: A scoping review

Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014

Drug Resistance in Bacteria, Fungi, Malaria, and Cancer

Contact Info

Product

Resources

About